Un gran avance: Gritgen Therapeutics ha completado la inscripción de pacientes en el primer ensayo de terapia génica para la hemofilia A iniciado por investigadores en China y también ha completado la dosis al primer paciente en el ensayo de Fase... - Iberonews iberonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iberonews.com Daily Mail and Mail on Sunday newspapers.
Exciting Progress | Gritgen Therapeutics Completed Patients Enrollment in China's First Gene Therapy Investigator-Initiated Trial for Hemophilia A and also Achieved the First Patient Dosed in China Phase I Trial in Patients with Severe Hemophilia A - Iberonews iberonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iberonews.com Daily Mail and Mail on Sunday newspapers.